Krystal Biotech (KRYS) Tax Provisions (2023 - 2026)
Krystal Biotech (KRYS) reported Tax Provisions of $5.5 million for Q1 2026, down 30.06% on a YoY basis from $7.9 million in Q1 2025, and up 2215.38% sequentially from -$260000.0 in Q4 2025.
Krystal Biotech (KRYS) Tax Provisions (2023 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 4 years of Tax Provisions data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 30.06% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at -$17.8 million (down 226.19% YoY), and the FY2025 full-year result was -$15.4 million, down 347.86% from the prior year.
- Tax Provisions grew to $5.5 million in Q1 2026, from -$260000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $8.4 million in Q2 2025 to a low of -$31.4 million in Q3 2025.
- A 4-year average of -$191222.2 and a median of $2.6 million in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 1661.01% in 2025, while the deepest fall reached 1307.62% in 2025.
- Tracing KRYS's Tax Provisions over 4 years: stood at $2.0 million in 2023, then soared by 59.34% to $3.1 million in 2024, then plunged by 108.3% to -$260000.0 in 2025, then surged by 2215.38% to $5.5 million in 2026.
- Business Quant data shows KRYS's Tax Provisions at $5.5 million in Q1 2026, -$260000.0 in Q4 2025, and -$31.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Krystal Biotech | 9.84 Bn | 9.02 Bn | 110.08 Mn | 5.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.50 Mn |
| Dec 31, 2025 | -260,000.00 |
| Sep 30, 2025 | -31.40 Mn |
| Jun 30, 2025 | 8.40 Mn |
| Mar 31, 2025 | 7.86 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 477,000.00 |
| Dec 31, 2023 | 1.97 Mn |